898 related articles for article (PubMed ID: 25104089)
1. Metastasis review: from bench to bedside.
Alizadeh AM; Shiri S; Farsinejad S
Tumour Biol; 2014 Sep; 35(9):8483-523. PubMed ID: 25104089
[TBL] [Abstract][Full Text] [Related]
2. From bench to bedside: does preclinical practice in translational oncology need some rebuilding?
Bertotti A; Trusolino L
J Natl Cancer Inst; 2013 Oct; 105(19):1426-7. PubMed ID: 24052623
[No Abstract] [Full Text] [Related]
3. Translational oncology toward benefiting cancer patients: the Sun Yat-sen University Cancer Center experience.
Guerin M; Qian C; Zhong Q; Cui Q; Guo Y; Bei J; Shao J; Zhu X; Huang W; Wu J; Liu R; Liu Q; Wang J; Jia W; Zheng X; Zeng Y
Sci China Life Sci; 2016 Oct; 59(10):1057-1062. PubMed ID: 23132500
[No Abstract] [Full Text] [Related]
4. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
[TBL] [Abstract][Full Text] [Related]
5. TGF-β signaling in cancer metastasis.
Xie F; Ling L; van Dam H; Zhou F; Zhang L
Acta Biochim Biophys Sin (Shanghai); 2018 Jan; 50(1):121-132. PubMed ID: 29190313
[TBL] [Abstract][Full Text] [Related]
6. [Targeted based therapies in metastatic breast cancer: future evolution].
Belmondo L; Montana M; Curti C; Crozet M; Rathelot P; Penot-Ragon C; Vanelle P
Therapie; 2012; 67(6):491-503. PubMed ID: 23249575
[TBL] [Abstract][Full Text] [Related]
7. Aberrant B-Raf signaling in human cancer -- 10 years from bench to bedside.
Röring M; Brummer T
Crit Rev Oncog; 2012; 17(1):97-121. PubMed ID: 22471666
[TBL] [Abstract][Full Text] [Related]
8. Role of myeloid-derived suppressor cells in metastasis.
Cole K; Pravoverov K; Talmadge JE
Cancer Metastasis Rev; 2021 Jun; 40(2):391-411. PubMed ID: 33411082
[TBL] [Abstract][Full Text] [Related]
9. [Together, towards precise oncology!].
Coukos G; Michielin O; Dietrich P; Aapro M
Rev Med Suisse; 2014 May; 10(431):1099-100. PubMed ID: 24941676
[No Abstract] [Full Text] [Related]
10. The metastatic process: methodological advances and pharmacological challenges.
Mazzocca A; Carloni V
Curr Med Chem; 2009; 16(14):1704-17. PubMed ID: 19442141
[TBL] [Abstract][Full Text] [Related]
11. Tissue invasion and metastasis: Molecular, biological and clinical perspectives.
Jiang WG; Sanders AJ; Katoh M; Ungefroren H; Gieseler F; Prince M; Thompson SK; Zollo M; Spano D; Dhawan P; Sliva D; Subbarayan PR; Sarkar M; Honoki K; Fujii H; Georgakilas AG; Amedei A; Niccolai E; Amin A; Ashraf SS; Ye L; Helferich WG; Yang X; Boosani CS; Guha G; Ciriolo MR; Aquilano K; Chen S; Azmi AS; Keith WN; Bilsland A; Bhakta D; Halicka D; Nowsheen S; Pantano F; Santini D
Semin Cancer Biol; 2015 Dec; 35 Suppl():S244-S275. PubMed ID: 25865774
[TBL] [Abstract][Full Text] [Related]
12. Permissive role of endothelin receptors in tumor metastasis.
Said N; Theodorescu D
Life Sci; 2012 Oct; 91(13-14):522-7. PubMed ID: 22846215
[TBL] [Abstract][Full Text] [Related]
13. Immune Targeting of Tetraspanins Involved in Cell Invasion and Metastasis.
Vences-Catalán F; Levy S
Front Immunol; 2018; 9():1277. PubMed ID: 29946318
[TBL] [Abstract][Full Text] [Related]
14. Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy.
Iiizumi M; Liu W; Pai SK; Furuta E; Watabe K
Biochim Biophys Acta; 2008 Dec; 1786(2):87-104. PubMed ID: 18692117
[TBL] [Abstract][Full Text] [Related]
15. Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer.
Deep G; Agarwal R
Cancer Metastasis Rev; 2010 Sep; 29(3):447-63. PubMed ID: 20714788
[TBL] [Abstract][Full Text] [Related]
16. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
17. The biological framework: translational research from bench to clinic.
Yarden Y
Oncologist; 2011; 16 Suppl 1():23-9. PubMed ID: 21278438
[TBL] [Abstract][Full Text] [Related]
18. Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development.
Stahel R; Bogaerts J; Ciardiello F; de Ruysscher D; Dubsky P; Ducreux M; Finn S; Laurent-Puig P; Peters S; Piccart M; Smit E; Sotiriou C; Tejpar S; Van Cutsem E; Tabernero J
Cancer Treat Rev; 2015 Feb; 41(2):129-35. PubMed ID: 25533737
[TBL] [Abstract][Full Text] [Related]
19. Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy.
Li L; Tang P; Li S; Qin X; Yang H; Wu C; Liu Y
Med Oncol; 2017 Sep; 34(10):180. PubMed ID: 28918490
[TBL] [Abstract][Full Text] [Related]
20. [Invasion patterns and metastasis of urothelial carcinoma. A challenge for translational research].
Bolenz C; Martini T; Michel MS
Urologe A; 2013 Sep; 52(9):1242-7. PubMed ID: 23979445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
